Abstract:

Objective: To evaluate retrospectively the data of crystallized phenol administration in recurrent recurrence of Pilonidal sinus patients undergoing modified Limberg method. MATERIAL AND METHODS: Thirty-two patients who had previously undergone a modified limberg flap technique due to primary pilonidal disease were included in the study between January 2016 - January 2017. Patients were evaluated in terms of age, gender, number of applications, wound infection, recurrence and average follow-up time. Results: The data of 32 patients with recurrent pilonidal disease and the crystallized phenol administration data were analyzed. The average age was 24.4±5.3 years. Five (15.6%) were female and 27 (84.4%) were male. Crystalline phenol application was administered once in 22 (68. 75%) patients, twice in 5 (15.6%) patients and three times in 2 (6.25%) patients. Three patients (9.3%) did not recover and were treated with other flap methods. Once crystallized phenol was administered, 22 (68.75%) of the patients, 26 (81.25%) with two applications, and 31 (90.7%) of treatment were provided with 3 treatments. Three (9.3%) patients developed wound infection. The average follow-up time was 13.1±6.4 months. During the follow-up, recurrence occurred in 2 (6.8%) patients. CONCLUSIONS: Although flap methods used in the treatment of pilonidal sinus disease have reduced the recurrence rate compared to other surgical methods, relapse still seems to be a serious problem. We believe that crystallized phenol method can be better in terms of recurrent pilonidal sinus disease and low recurrence rates compared to flap methods. However, we think there is a need for extensive research.

Keywords:

Abstract:

OBJECTIVE: To evaluate retrospectively the data of crystallized phenol administration in recurrent recurrence of Pilonidal sinus patients undergoing modified Limberg method. MATERIAL AND METHODS: Thirty-two patients who had previously undergone a modified limberg flap technique due to primary pilonidal disease were included in the study between January 2016 - January 2017. Patients were evaluated in terms of age, gender, number of applications, wound infection, recurrence and mean follow-up time. RESULTS: The data of 32 patients with recurrent pilonidal disease and the crystallized phenol administration data were analyzed. The mean age was 24.4±5.3 years. Five (15.6%) were female and 27 (84.4%) were male. Crystalline phenol application was administered once in 22 (68.75%) patients, twice in 5 (15.6%) patients and three times in 2 (6.25%) patients. Three patients (9.3%) did not recover and were treated with other flap methods. Once crystallized phenol was administered, 22 (68.75%) of the patients, 26 (81.25%) with two applications, and 31 (90.7%) of treatment were provided with 3 treatments. Three (9.3%) patients developed wound infection. The mean follow-up time was 13.1±6.4 months. During follow-up, recurrence occurred in 2 (6.8%) patients. CONCLUSIONS: Although flap methods used in the treatment of pilonidal sinus disease have reduced the recurrence rate compared to other surgical methods, relapse still seems to be a serious problem. We believe that crystallized phenol method can be beterness in terms of recurrent pilonidal sinus disease and low recurrence rates compared to flap methods. However, we think that there is a need for extensive research.